US FDA clears first diagnostic imaging review app for iPads and iPhones
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has cleared for the first time a mobile diagnostic imaging review application for use on the iPad and iPhone manufactured by Apple1.